TrialFrontiers in immunology2021

Non-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19.

Zachary M Holliday et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.